SM
MEDP icon

Sciencast Management’s Medpace MEDP Stock Holding History

Sciencast Management’s Portfolio MEDP Stock Details MEDP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-939
Closed -$227K – 349
2023
Q3 		$227K Buy
+939
New +$240K 0.1% 276
2021
Q3 		– Sell
-3,101
Closed -$569K – 522
2021
Q2 		$569K Buy
+3,101
New +$535K 0.12% 250
2021
Q1 		– Sell
-4,561
Closed -$638K – 606
2020
Q4 		$638K Buy
4,561
+1,907
+72% +$240K 0.13% 228
2020
Q3 		$331K Buy
+2,654
New +$307K 0.13% 260

Other funds holding MEDP

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
RP
Riverbridge Partners Minneapolis, Minnesota $3.58B AUM 4.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BTW
Boston Trust Walden Boston, Massachusetts $12.2B AUM 12.45% 1-Year Est. Return
TD Asset Management
TD Asset Management Toronto, Ontario, Canada $123B AUM 34.51% 1-Year Est. Return

Sciencast Management's MEDP Position: Q4 2023 in Review

Sciencast Management sold out of Medpace (MEDP) in Q4 2023, closing a stake of 939 shares — an estimated $227K sold.

Sciencast Management first reported a position in MEDP in Q3 2020 and held it in 4 quarters. The position peaked at $638K in Q4 2020. 544 funds tracked by Wall St. Rank hold MEDP as of Q4 2023.

  • Sciencast Management reported no remaining Medpace position as of Q4 2023 after selling out during the quarter.
  • Sciencast Management sold 939 Medpace shares in Q4 2023, an estimated $227K.
  • Sciencast Management first reported a position in Medpace in Q3 2020 and held it in 4 quarters.
  • Sciencast Management's Medpace position peaked at $638K in Q4 2020.
  • 544 funds tracked by Wall St. Rank held Medpace as of Q4 2023.

Based on Sciencast Management's 13F filing for Q4 2023, filed 14 Feb 2024.